← Leaderboards
Edward Giovannucci
Brigham And Women'S Hospital
$20,500,695
Attributed
$24,796,493
Total exposure
16
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,796,493 · 16
By mechanism
P01$9,383,431 · 5
R01$7,461,908 · 5
U01$6,443,697 · 1
U19$1,029,603 · 1
R03$477,854 · 3
P50$0 · 1
Top collaborators
- Deirdre Kay Tobias4 shared
- Xuehong Zhang4 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Charles S Fuchs$37,354,862
- Howard D Sesso$5,697,818
- Shelley S Tworoger$12,562,498
- Meryl S Leboff$9,246,227
- Naomi D Fisher$3,265,682
Others in their field
Top investigators on “Obesity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S. Currier · University Of California Los Angeles$139,907,800
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
ObesityPathway InteractionsCohortMalignant NeoplasmsCancer RiskEtiologyPlasmaMediatingRisk FactorsDiagnosisInflammatoryBaseEnergy BalanceTumorDietIncidenceInflammationAspirinColorectal CancerVitamin DPhysical ActivityGenesC-PeptideTissues
Grant awards (51)
Decoding mechanisms underlying metabolic dysregulation in obesity and digestive cancer risk$2,595,836
U01 · FY2025 · CA
Association between pre-diagnosis hepatic fat infiltration and risk of liver metastasis and mortality in a large cohort of stage I-III colorectal cancer survivors$687,694
R01 · FY2025 · CA · contact PI
Decoding mechanisms underlying metabolic dysregulation in obesity and digestive cancer risk$1,233,023
U01 · FY2024 · CA
Association between pre-diagnosis hepatic fat infiltration and risk of liver metastasis and mortality in a large cohort of stage I-III colorectal cancer survivors$641,777
R01 · FY2024 · CA · contact PI
Decoding mechanisms underlying metabolic dysregulation in obesity and digestive cancer risk$1,271,961
U01 · FY2023 · CA
Association between pre-diagnosis hepatic fat infiltration and risk of liver metastasis and mortality in a large cohort of stage I-III colorectal cancer survivors$674,019
R01 · FY2023 · CA · contact PI
Decoding mechanisms underlying metabolic dysregulation in obesity and digestive cancer risk$1,342,877
U01 · FY2022 · CA
Association between pre-diagnosis hepatic fat infiltration and risk of liver metastasis and mortality in a large cohort of stage I-III colorectal cancer survivors$713,116
R01 · FY2022 · CA · contact PI
Impact of screening and diagnostic intensity on the study of prostate cancer epidemiology$79,750
R03 · FY2020 · CA · contact PI
Project 2: Colorectal Cancer$406,739
P01 · FY2019 · CA · contact PI
Predicted lean body mass, fat mass, and risk of lung, pancreatic, colorectal, breast, and prostate cancers$79,750
R03 · FY2019 · CA · contact PI
Impact of screening and diagnostic intensity on the study of prostate cancer epidemiology$79,750
R03 · FY2019 · CA · contact PI
Project 2: Colorectal Cancer$418,382
P01 · FY2018 · CA · contact PI
Predicted lean body mass, fat mass, and risk of lung, pancreatic, colorectal, breast, and prostate cancers$79,750
R03 · FY2018 · CA · contact PI
Weight cycling and total and site-specific cancer incidence and mortality$79,500
R03 · FY2018 · CA · contact PI
Project 2: Colorectal Cancer$418,382
P01 · FY2017 · CA · contact PI
Weight cycling and total and site-specific cancer incidence and mortality$79,354
R03 · FY2017 · CA · contact PI
Project 2: Colorectal Cancer$421,096
P01 · FY2016 · CA · contact PI
Project 2: Colorectal Cancer$440,299
P01 · FY2015 · CA · contact PI
Colorectal Cancer$419,513
P01 · FY2014 · CA · contact PI
Colorectal Cancer$493,268
P01 · FY2013 · CA · contact PI
Energy Balance-Related Hormones & Prostate Cancer Incidence & Progression$625,460
R01 · FY2012 · CA · contact PI
Colorectal Cancer$446,568
P01 · FY2012 · CA · contact PI
Energy Balance-Related Hormones & Prostate Cancer Incidence & Progression$633,508
R01 · FY2011 · CA · contact PI
A Prospective Study of Diet and Prostate Cancer$583,177
U19 · FY2011 · CA · contact PI
Colorectal Cancer$450,670
P01 · FY2011 · CA · contact PI
Energy Balance-Related Hormones & Prostate Cancer Incidence & Progression$661,653
R01 · FY2010 · CA · contact PI
Colorectal Cancer$462,992
P01 · FY2010 · CA · contact PI
A Prospective Study of Diet and Prostate Cancer$446,426
U19 · FY2010 · CA · contact PI
DIET, HORMONES, AND RISK OF COLORECTAL CANCER$843,303
P01 · FY2009 · CA · contact PI
Energy Balance-Related Hormones & Prostate Cancer Incidence & Progression$680,013
R01 · FY2009 · CA · contact PI
A Prospective Study of Diet and Prostate Cancer$516,807
P01 · FY2009 · CA · contact PI
DIET, HORMONES, AND RISK OF COLORECTAL CANCER$822,171
P01 · FY2008 · CA · contact PI
Energy Balance-Related Hormones & Prostate Cancer Incidence & Progression$717,954
R01 · FY2008 · CA · contact PI
A Prospective Study of Diet and Prostate Cancer$502,437
P01 · FY2008 · CA · contact PI
DIET, HORMONES, AND RISK OF COLORECTAL CANCER$833,359
P01 · FY2007 · CA · contact PI
A Prospective Study of Diet and Prostate Cancer$507,538
P01 · FY2007 · CA · contact PI
DIET, HORMONES, AND RISK OF COLORECTAL CANCER$497,482
P01 · FY2006 · CA · contact PI
DIET, HORMONES, AND RISK OF COLORECTAL CANCER$482,425
P01 · FY2005 · CA
RANDOMIZED TRIAL OF FOLATE AND COLORECTAL ADENOMA$232,103
R01 · FY2003 · CA
RANDOMIZED TRIAL OF FOLATE AND COLORECTAL ADENOMA$225,342
R01 · FY2002 · CA
DIET, HORMONES AND RISK OF COLORECTAL CANCERS$0
P01 · FY2002 · CA
Genetic and serologic determinants of prostate cancer risk and progression$0
P50 · FY2002 · CA
DIET, HORMONES AND RISK OF COLORECTAL CANCERS$0
P01 · FY2002 · CA
RANDOMIZED TRIAL OF FOLATE AND COLORECTAL ADENOMA$218,779
R01 · FY2001 · CA
DIET AND GENETIC INTERACTIONS IN PROSTATE CANCER$78,504
R01 · FY2001 · CA
DIET, HORMONES AND RISK OF COLORECTAL CANCERS$0
P01 · FY2001 · CA
NUTRITIONAL AND HORMONAL BIOMARKERS IN PROSTATE CANCER$383,773
R01 · FY2000 · CA
RANDOMIZED TRIAL OF FOLATE AND COLORECTAL ADENOMA$212,407
R01 · FY2000 · CA
DIET AND GENETIC INTERACTIONS IN PROSTATE CANCER$75,806
R01 · FY2000 · CA
DIET, HORMONES AND RISK OF COLORECTAL CANCERS$0
P01 · FY2000 · CA